Skip to content
StarCore Network

Zimbabwe Turns Down ‘Lopsided’ American Healthcare Assistance Package Due to Information Concerns

Health aid illustration
The proposed US financial assistance would have supported initiatives for treating and preventing HIV/Aids, tuberculosis, and malarial diseases.

Zimbabwe has rejected a significant American health deal valued at $367m (272 million pounds) over five years due to the United States' request for confidential information.

This rejection became public after a internal memorandum from December was leaked, which showed Head of State Emmerson Mnangagwa felt the agreement was "unbalanced".

A government spokesperson has since explained that the US was seeking genetic material for research and commercial purposes but was unwilling to guarantee the benefits from future medical innovations.

"We must now begin the challenging and unfortunate process of winding down our health assistance in Zimbabwe," stated US ambassador to Zimbabwe Pamela Tremont publicly.

Her embassy noted the United States had provided over $1.9bn as health assistance to Zimbabwe during the past twenty years.

A physicians' group in Zimbabwe has urged continued dialogue to find a agreement suitable to all parties so the country's vital HIV programme can be sustained.

Wider Context

This development follows a similar situation in Kenya, where a high court halted a similar health funding agreement after legal challenges were filed about the security of Kenyans' medical information.

After returning to the presidency recently, US President Donald Trump has reduced overseas assistance and shut down the US Agency for International Development (USAID).

The agency had administered assistance for the American government, but Trump argued its expenditure was "inefficient" and his administration was seeking direct bilateral deals to boost openness and accountability.

As per reports, 16 nations in Africa have to date agreed to similar health pacts, constituting over $18.3bn of fresh investment.

Specifics of the Declined Deal

The funds for Zimbabwe would have funded "tackling HIV/Aids, tuberculosis, malaria, healthcare for mothers and children, and preparing for epidemics".

"It is our view this partnership would have delivered extraordinary advantages for the people of Zimbabwe, particularly the 1.2 million men, women and children currently receiving antiretroviral therapy through US-supported initiatives," the Ambassador added.

However, official spokesman Nick Mangwana said the proposed deal was "asymmetrical".

"Zimbabwe was being asked to surrender its genetic material and health information over an extended period, without any equivalent promise of access to any medical innovations – like vaccines, diagnostics, or treatments – that might be developed from that shared data," his statement read.

"In essence, our nation would supply the raw materials for medical research without any certainty that the final treatments would be available to our people should a new health crisis emerge."

Sovereignty and Global Health

Mangwana further said that the American exit from the World Health Organization (WHO) and its push of one-on-one health agreements were disrupting frameworks already established via the international health agency.

Mangwana gave as an example its Pandemic Benefit-Sharing framework designed to deal with future pandemics.

"This system is designed to guarantee that when a country provides its data, the resulting advantages – including medicines and cures – are shared equitably, not commercialised solely by those with the resources to develop them."

These objections over the US deal "must not be interpreted as opposition to America," he added.

"We encourage continued discussions with our US partners on how subsequent co-operation could be arranged in a way that honours the independence and interests of each country."

Health Experts Reaction

Medical experts said it recognised the government's concerns, but suggested that negotiations must proceed since a large portion of the country's Aids initiatives depended on international support.

"Where technical issues arise, such as those involving information security or implementation frameworks, these can often be addressed via technical clarification and mutually agreed protections," the group commented.

This impasse underscores the complex tensions between accepting much-needed foreign assistance and safeguarding national sovereignty in an increasingly data-driven world.

KH
By

Kimberly Hayden

A seasoned tech journalist with over a decade of experience covering cybersecurity and digital transformation across European markets.

StarCore Network

Type to search articles.